Cabazitaxel: a novel microtubule inhibitor. - sprookjes - yvandenbroek - TriplyDB

Cabazitaxel: a novel microtubule inhibitor.

Cabazitaxel: a novel microtubule inhibitor.

http://www.wikidata.org/entity/Q37902641

about

Efficacy of cabazitaxel in mouse models of pediatric brain tumors Cabazitaxel-induced stabilization of microtubules enhances radiosensitivity in ovarian cancer cells Role of the EpCAM (CD326) in prostate cancer metastasis and progression.Cabazitaxel: a guide to its use in hormone-refractory metastatic prostate cancer.Pharmaceuticals that contain polycyclic hydrocarbon scaffolds.Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer.The expanding role of chemotherapy in prostate cancer.Cabazitaxel operates anti-metastatic and cytotoxic via apoptosis induction and stalls brain tumor angiogenesis.Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive Agents Metabolism of TM-2, a potential antitumor drug, in rats by using LC-MS.Characterization of in vitro metabolites of TM-2, a potential antitumor drug, in rat, dog and human liver microsomes using liquid chromatography/tandem mass spectrometry.No significant impact of prior treatment profile with docetaxel on the efficacy of cabazitaxel in Japanese patients with metastatic castration-resistant prostate cancer.Advances in the management of high-risk localised and metastatic prostate cancer.

P2860

Q35788771-DBAD9750-02F5-4498-BF99-43391A857213 Q37180823-BF8E7CBE-4479-470A-82F4-9FC73285C13D Q38020426-02F748A3-524B-4205-B30F-AEE587F0F858 Q38093471-08AD6BF2-D984-4D0D-B2B0-D34A1AEFD7FD Q38546598-5AD03D1B-5D3D-4E0D-A726-A57B62798032 Q38919065-603AE7A7-C865-4B35-ACD6-37023F43E413 Q38967484-1419A2D1-09BD-4C69-9760-31544A4189E5 Q39749702-94E658DE-0149-4031-A93C-4E094F937B48 Q42755952-CEE983C0-A9CC-4845-8488-79E6CD58D906 Q46055849-CEB35A96-BF23-4F69-95D4-89B9E4586DDB Q46844576-EE5F1302-D926-49B4-AE61-73D6052B31BE Q48110667-72D7881F-B60A-495B-86FE-79F84049452B Q51176152-2D0C8B28-7047-4141-A42A-ED7BA8B31663

P2860

Cabazitaxel: a novel microtubule inhibitor.

http://www.wikidata.org/entity/Q37902641

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cabazitaxel: a novel microtubule inhibitor.

@en

Cabazitaxel: a novel microtubule inhibitor.

@nl

type

label

Cabazitaxel: a novel microtubule inhibitor.

@en

Cabazitaxel: a novel microtubule inhibitor.

@nl

prefLabel

Cabazitaxel: a novel microtubule inhibitor.

@en

Cabazitaxel: a novel microtubule inhibitor.

@nl

P1433

Q37902641-235179EA-F984-4F3B-B080-A7B83992D384

P1476

Q37902641-4A9093B9-277A-4EBC-9BBB-0C2AA5960048

P2093

Q37902641-0477DE0B-E9C9-4C2C-BC3A-2911A5D5EFDF

Q37902641-0C8284D6-CC19-4966-B91B-1C145CEEC056

Q37902641-19D8E530-0B50-4C98-B4A0-26F3D5DD38AF

Q37902641-1EA63165-C6EA-40E4-8130-64E6CC114751

Q37902641-2FFA506E-F89F-40E7-9DE9-722664D1C2AB

Q37902641-68E6FE8B-A4FB-4D2D-B58C-3CD0E5D3E3A2

Q37902641-73A527A4-F5F8-46DD-B46B-40720BF1C7B7

Q37902641-814770E7-535E-40E8-AC38-EADF60F549F5

Q37902641-882E1B03-8EE8-4FA7-A071-04FB948475B9

Q37902641-A442BE02-4205-4204-940F-4453F496AD34

P2860

Q37902641-13520A23-B937-4E44-9B91-96792F864FA9

Q37902641-233F2297-C981-4950-A59E-DCC0D1C29B68

Q37902641-2BC8ED98-CC64-4F93-9EF0-6276A6DA84CF

Q37902641-30579220-75B4-4841-A758-919043ED8C31

Q37902641-436FBEEB-3ECD-4C7F-A84D-880EDE73E5BF

Q37902641-6220A11A-913C-4276-B0B4-02FEE982753B

Q37902641-662C5FB1-4C3E-46AD-8CF3-F82581A15C31

Q37902641-67F16588-8992-489F-9D2E-B19B129BCC1E

Q37902641-708074B4-A35E-4170-B597-1A60354454D7

Q37902641-90B6E36A-7B2B-4F0A-9A8C-9F66D12A0B99

P2888

Q37902641-405EC33B-4BE5-4D8D-86CF-7F4E8EE5350B

P304

Q37902641-6065C7EA-F8C9-4865-9BFB-63C231715A54

P31

Q37902641-0FBFE686-8B74-48FD-96D6-7B3BA5368BC1

P356

Q37902641-0F8B0C4D-D34E-4349-97EF-8FC8570E2500

P433

Q37902641-6CDEC93B-A3FF-48D9-B116-A738EBD1A67B

P478

Q37902641-9D124438-4027-450E-9E76-7DD3D6F75A29

P577

Q37902641-56644EE6-81B8-4202-ADC1-DCA5CA44FFB3

P6179

Q37902641-ABB406C9-7A86-43FA-A0FC-70265F663080

P698

Q37902641-97C4A9F3-936A-4BBA-A1AF-608AE5FA2AB8

P921

Q37902641-DE97A91D-9E56-4990-934C-7E4FF0199E97

P356

11591390-000000000-00000

P1433

P1476

Cabazitaxel: a novel microtubule inhibitor.

@en

P2093

Antoine Thiery-Vuillemin

http://www.w3.org/2001/XMLSchema#string

Cristian Villanueva

http://www.w3.org/2001/XMLSchema#string

Erion Dobi

http://www.w3.org/2001/XMLSchema#string

Fernando Bazan

http://www.w3.org/2001/XMLSchema#string

Laurent Cals

http://www.w3.org/2001/XMLSchema#string

Loïc Chaigneau

http://www.w3.org/2001/XMLSchema#string

Martin Demarchi

http://www.w3.org/2001/XMLSchema#string

Stefano Kim

http://www.w3.org/2001/XMLSchema#string

Thierry Nguyen

http://www.w3.org/2001/XMLSchema#string

Xavier Pivot

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial.

The blood-brain barrier and oncology: new insights into function and modulation.

Update on tubulin-binding agents.

Nonlinear accumulation in the brain of the new taxoid TXD258 following saturation of P-glycoprotein at the blood-brain barrier in mice and rats.

Thymidine phosphorylase expression in tumour cells and tumour response to capecitabine plus docetaxel chemotherapy in non-small cell lung cancer

Novel agents that target tublin and related elements.

P2888

11591390-000000000-00000

P304

1251-1258

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/11591390-000000000-00000

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1049654449

http://www.w3.org/2001/XMLSchema#string

P698

21770474

http://www.w3.org/2001/XMLSchema#string

P921